In a surprising turn of events, Ford Motor’s U.S. new vehicle sales have seen a significant increase of 11.2% compared to the same month of the previous year. This growth is primarily attributed to the strong sales of all-electric and hybrid models. Ford reported a remarkable 65% increase in sales of both hybrid and all-electric
Business
Recently, CNBC’s David Faber reported that Paramount and Skydance have finalized the terms of a merger that could potentially be announced in the upcoming days. This merger involves a buying consortium led by David Ellison’s Skydance, with the support of private equity firms RedBird Capital and KKR, reaching an agreement with a special committee at
Jeep is planning to increase its U.S. sales of plug-in hybrid electric vehicles (PHEVs) by up to 50% this year, positioning the technology as a transitional solution between traditional gas-guzzling SUVs and fully electric vehicles. This move comes in response to a slower-than-expected sales pace of electric vehicles (EVs) in the market. As part of
Moderna and Merck revealed groundbreaking data on their experimental vaccine for patients with advanced melanoma, presented at the American Society of Clinical Oncology annual meeting in Chicago. The combination of the vaccine and Keytruda therapy exhibited significant improvements in survival rates and long-lasting efficacy, offering hope to patients with this deadly form of skin cancer.
The co-founder of the fintech startup Yotta, Adam Moelis, set out with the noble intention of providing Americans with a new way to save money. Unfortunately, what started as a promising endeavor has now turned into a nightmare for thousands of customers. A dispute between Yotta’s banking partners, Synapse and Evolve Bank & Trust, has
Pfizer’s groundbreaking drug, Lorbrena, has demonstrated revolutionary progress in the treatment of advanced non-small cell lung cancer. Recent long-term results from a late-stage trial have showcased the drug’s ability to significantly extend the lifespan of patients while preventing the progression of cancer. With a remarkable data showing that most individuals experienced positive outcomes for over